Showing results (2911-2920 of 5,227) with videos related to
Sort By:
Pageof 523
Antiviral Research|December 13, 2022
A stable hepatitis D virus-producing cell line for host target and drug discoveryCharlotte Bach, Julie Lucifora, Marion Delphin, et al.Antiviral Research|December 8, 2022
Phenothiazines inhibit SARS-CoV-2 cell entry via a blockade of spike protein binding to neuropilin-1Mei Hashizume, Ayako Takashima, Chikako Ono, et al.Antiviral Research|January 2, 2023
Identification of critical residues in the regulatory protein HBx for Smc5/6 interaction and hepatitis B virus productionLili He, Huanyu Shen, Hui Deng, et al.Antiviral Research|January 2, 2023
Development of a rapid image-based high-content imaging screening assay to evaluate therapeutic antibodies against the monkeypox virusKrishna P Kota, Natasza E Ziółkowska, Jiayi Wei, et al.Antiviral Research|January 5, 2023
A small molecule that targets the processivity factor of molluscum contagiosum virus has therapeutic potentialHancheng Guan, Manunya Nuth, Stuart N Isaacs, et al.Antiviral Research|January 5, 2023
Inhibition of Chikungunya virus genome replication by targeting essential RNA structures within the virus genomeOliver Prosser, Nicola J Stonehouse, Andrew TuplinAntiviral Research|January 19, 2023
Interferon-induced restriction of Chikungunya virus infectionYouichi SuzukiAntiviral Research|January 22, 2023
Development of highly effective LCB1-based lipopeptides targeting the spike receptor-binding motif of SARS-CoV-2Yuanmei Zhu, Min Li, Nian Liu, et al.Antiviral Research|December 24, 2022
Development of a robust and convenient dual-reporter high-throughput screening assay for SARS-CoV-2 antiviral drug discoveryWinston Chiu, Joost Schepers, Thibault Francken, et al.Antiviral Research|December 25, 2022
A pan-serotype antiviral to prevent and treat dengue: A journey from discovery to clinical development driven by public-private partnershipsOlivia Goethals, Natalia V Voge, Bart Kesteleyn, et al.Pageof 523